Deaths and complications associated with the management of acute immune thrombotic thrombocytopenic purpura-Reference-Cited by-同舟云学术

Deaths and complications associated with the management of acute immune thrombotic thrombocytopenic purpura

Published:2020-02-21 Issue:4 Volume:60 Page:841-846
ISSN:0041-1132
Container-title:Transfusion
language:en
Short-container-title:Transfusion

Author:

Colling Meaghan¹²,Sun Lova²³,Upadhyay Vivek²³,Ryu Justine²⁴,Li Ang⁵,Uhl Lynne²⁶,Kaufman Richard M.²⁷^ORCID,Stowell Christopher P.¹²,Dzik Walter H.¹²⁸,Makar Robert S.¹²,Bendapudi Pavan K.¹²⁴⁸^ORCID

Affiliation:

1. Blood Transfusion Service, Department of PathologyMassachusetts General Hospital Boston Massachusetts

2. Harvard Medical School Boston Massachusetts

3. Department of MedicineMassachusetts General Hospital Boston Massachusetts

4. Division of Hemostasis and ThrombosisBeth Israel Deaconess Medical Center Boston Massachusetts

5. Department of MedicineUniversity of Washington Medical Center Seattle Washington

6. Department of PathologyBeth Israel Deaconess Medical Center Boston Massachusetts

7. Department of PathologyBrigham and Womenʼs Hospital Boston Massachusetts

8. Division of HematologyMassachusetts General Hospital Boston Massachusetts

Funder

National Institutes of Health

Publisher

Wiley

Subject

Hematology,Immunology,Immunology and Allergy

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/trf.15721

Reference20 articles.

1. THROMBOTIC THROMBOCYTOPENIC PURPURA

2. Comparison of Plasma Exchange with Plasma Infusion in the Treatment of Thrombotic Thrombocytopenic Purpura

3. Impact of severe ADAMTS13 deficiency on clinical presentation and outcomes in patients with thrombotic microangiopathies: the experience of the Harvard TMA Research Collaborative

4. Complications of plasma exchange in patients treated for clinically suspected thrombotic thrombocytopenic purpura-hemolytic uremic syndrome

5. Complications of plasma exchange in thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: a study of 78 additional patients

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Systematic Review of the Epidemiology and Disease Burden of Congenital and Immune-Mediated Thrombotic Thrombocytopenic Purpura;Journal of Blood Medicine;2024-08

2. Risk factors of death or chronic renal replacement therapy requirements in patients with thrombotic microangiopathies without ADAMTS‐13 deficiency;European Journal of Haematology;2024-07-02

3. Recombinant ADAMTS13 for Immune Thrombotic Thrombocytopenic Purpura;New England Journal of Medicine;2024-05-09

4. A descriptive analysis of fatal outcomes in immune thrombotic thrombocytopenic purpura in the USTMA TTP Registry;Blood Advances;2024-02-13

5. Global Health Resource Utilization and Cost-Effectiveness of Therapeutics and Diagnostics in Immune Thrombotic Thrombocytopenic Purpura (TTP);Journal of Clinical Medicine;2023-07-25